ZAI LAB LIMITED

Business Segments Zai Lab Limited

Stocks

ZLAB

US98887Q1040

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-18 EDT			5-day change	1st Jan Change
18.18 ^USD	+1.68%		+6.50%	+3.06%

06-16	Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug	MT
06-10	Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Biotechnology						144M	215M	267M	399M	460M
Total Assets						1.61B	1.22B	1.04B	1.19B	1.17B
Interest Expense						-	-	-	-2.25M	-5.21M
Income Tax Expense						-	-	-	-	-2.93M
CAPEX						-18.95M	-24.98M	-7.21M	-5.66M	-8.1M
EBT						-703M	-443M	-335M	-257M	-178M
Gross Profit						-	-	-	-	-
D&A						6.49M	8.23M	9.03M	11.86M	15.01M
Operating Income						-700M	-404M	-367M	-282M	-229M
Net Income						-704M	-443M	-335M	-257M	-176M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
People's Republic of China (PRC)						144M	-	-	399M	460M
Total Assets						1.61B	-	-	1.19B	1.17B
Interest Expense						-	-	-	-2.25M	-5.21M
Income Tax Expense						-	-	-	-	-2.93M
D&A						6.49M	-	-	11.86M	15.01M
CAPEX						-18.95M	-	-	-5.66M	-8.1M
Gross Profit						-	-	-	-	-
Net Income						-704M	-	-	-257M	-176M
EBT						-703M	-	-	-257M	-178M
Operating Income						-700M	-	-	-282M	-229M

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

×